Human C-reactive protein does not bind to FcgammaRIIa on phagocytic cells. 2001

E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel

UI MeSH Term Description Entries
D010586 Phagocytes Cells that can carry out the process of PHAGOCYTOSIS. Phagocyte,Phagocytic Cell,Phagocytic Cells,Cell, Phagocytic,Cells, Phagocytic
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation
D017452 Receptors, IgG Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor). Antigens, CD16,Antigens, CD32,Antigens, CD64,CD16 Antigens,CD32 Antigens,CD64 Antigen,CD64 Antigens,Fc Gamma Receptor,Fc Receptors, gamma,Fc gamma Receptors,IgG Receptor,IgG Receptors,Leu-11 Antigen,Receptors, Fc gamma,gamma Fc Receptor,gamma Fc Receptors,CD 16 Antigens,CD 32 Antigens,CD 64 Antigens,CDw32 Antigens,Fc gamma RI,Fc gamma RII,Fc gamma RIII,Immunoglobulin G Receptor,Leu-11 Antigens,Antigen, CD64,Antigen, Leu-11,Antigens, CD 16,Antigens, CD 32,Antigens, CD 64,Antigens, CDw32,Antigens, Leu-11,Fc Receptor, gamma,Gamma Receptor, Fc,Leu 11 Antigen,Leu 11 Antigens,Receptor, Fc Gamma,Receptor, IgG,Receptor, Immunoglobulin G,Receptor, gamma Fc,Receptors, gamma Fc,gamma RI, Fc,gamma RII, Fc,gamma RIII, Fc,gamma Receptors, Fc

Related Publications

E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
September 2002, Journal of immunology (Baltimore, Md. : 1950),
E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
February 2000, The Journal of clinical investigation,
E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
November 2009, Circulation,
E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
January 2022, Scientific reports,
E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
February 2005, The international journal of biochemistry & cell biology,
E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
May 2004, Arteriosclerosis, thrombosis, and vascular biology,
E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
June 2007, Medical microbiology and immunology,
E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
December 2004, Arteriosclerosis, thrombosis, and vascular biology,
E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
February 2007, Biochemical and biophysical research communications,
E Saeland, and A van Royen, and K Hendriksen, and H Vilé-Weekhout, and G T Rijkers, and L A Sanders, and J G van de Winkel
August 2007, Cardiovascular research,
Copied contents to your clipboard!